A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

NCT06972446 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Lutikizumab
DRUG: Placebo
DRUG: Ravagalimab

Sponsor

AbbVie